Kiromic BioPharma, Inc.
KRBP · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $3 | $4 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $2 | $2 |
| Total Curr. Assets | $3 | $4 | $6 | $6 |
| Property Plant & Equip (Net) | $5 | $6 | $6 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $6 | $6 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9 | $10 | $12 | $13 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $2 | $2 |
| Short-Term Debt | $14 | $1 | $13 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$12 |
| Other Curr. Liab. | $4 | $17 | $2 | $4 |
| Total Curr. Liab. | $21 | $19 | $17 | $19 |
| LT Debt | $0 | $14 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | -$0 | $0 | $0 |
| Total NC Liab. | $0 | $14 | $1 | $1 |
| Other Liabilities | $0 | -$14 | $0 | $0 |
| Cap. Leases | $1 | $0 | $1 | $1 |
| Total Liabilities | $21 | $20 | $18 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$150 | -$143 | -$136 | -$129 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $137 | $134 | $131 | $122 |
| Total Equity | -$13 | -$9 | -$5 | -$7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9 | $10 | $12 | $13 |
| Net Debt | $13 | $12 | $9 | $10 |